Medicine
Neo-Synalar 0.25 mg/3.5 mg per g cream
Neo-Synalar 0.25 mg/3.5 mg per g cream is a prescription medicine containing Fluocinolone acetonide and Neomycin for topical use, marketed by Eurofarma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature 15-25°C (59-77°F), avoid freezing and excessive heat…
Key facts
- Active ingredient (INN)
- Fluocinolone acetonide and Neomycin
- Brand
- Neo-Synalar
- Strength
- 0.25 mg/3.5 mg per g
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 tube, 4 tubes
- Marketing authorisation holder
- Eurofarma
- Manufacturer
- Eurofarma
- Origin register
- US FDA, United States
- Storage
- Store at room temperature 15-25°C (59-77°F), avoid freezing and excessive heat above 40°C (104°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 11 June 1963
- Identifiers
- RxCUI 1191359, 1542994DailyMed set ID 1141956e-8a4c-4f80-95d1-f15bdb57fdf6NDC 43538-940Application ANDA060700
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | Approved | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Fluocinolone acetonide and Neomycin is a fixed-dose combination of an aminoglycoside antibacterial and a corticosteroid indicated for the treatment of corticosteroid-responsive dermatoses with secondary infection. It is available as cream for topical use. MedsAcross supplies Fluocinolone acetonide and Neomycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Fluocinolone acetonide and NeomycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Neo-Synalar prescribing information (Eurofarma) · U.S. National Library of Medicine, DailyMed
Need Neo-Synalar 0.25 mg/3.5 mg per g cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.